Questions and Answers on Bone Marrow
and Cord Blood Stem Cell Transplants
Question: What
is the cost and the steps to consider for bone marrow
transplant?
Answer: Evaluation for Bone Marrow Transplantation
is a long journey, because the risks and expenses
are large. Here is an outline of what would need
to be done to evaluate a child for possible bone marrow
transplantation:
1) SICKLE CELL ELIGIBILITY -- determine whether your
son has had severe enough sickle cell disease to make
the risks of bone marrow transplant worthwhile. A
summary of his medical history would be very helpful,
focusing on whether he has had stroke and chronic
transfusion, or very frequent hospital stays for pain
or for lung problems, or other major sickle cell problems.
2) OTHER MEDICAL ISSUES --- You should make your doctor
aware that your family is considering the bone marrow
transplant (BMT) option. Ask the doctor to let us
know whether there are any hidden medical problems
that would influence the decision, such as chronic
viral or other infections, problems with transfusion
reactions, other medical problems unrelated to sickle
cell, or anything else unusual. This does not have
to be a lengthy or formal statement from the doctor
at this point, more like a safety check to make sure
that we are not missing any huge medical issues. A
more complete medical record would be required later.
3) HLA-TYPING BLOOD TESTS --- Do immunologic typing
(HLA typing) of your child and the relative with the
highest probability of matching him - only brothers
or sisters from the same parents are really potential
donors, parents and half-siblings are very unlikely
to match unless there was an unusual family tree.
The HLA typing will cost several thousand dollars.
If the sibling is not a full HLA match, then it is
very unlikely that BMT can be done.
4) PRE-BMT EVALUATION -- after all of the above steps,
then a formal evaluation by the BMT team can begin.
This will include a very detailed look at his medical
history and current medical condition from head to
toe, plus your family's ability to cope with the BMT
process. Parents will need to plan to stay in the
Atlanta with the patient for a minimum of 8 months
for the pre-transplant evaluation, transplant stay,
and post-transplant follow-up. A financial arrangement
will need to be made, with an estimated cost for the
BMT process of $150,000 to $250,000. An outside expert
panel will review the case on ethical grounds.
5) BMT & early follow-up period - This is a risky
process, and the statistics are that there is a 5%
to 8% chance of death. Death can be caused by infection,
bleeding, toxic effects of the treatment, or the new
bone marrow engrafting and then attacking the rest
of the body. There is also a 10% to 12% chance that
the child could go through the BMT process but reject
the new bone marrow, ending up still having sickle
cell disease. Therefore, the overall success rate
of BMT for sickle cell disease is approximately 80%
to 85%, of being cured of sickle cell. These require
close medical followup, often in and out of the hospital
and office daily, and many medications daily.
Question: How is the Cord Blood Stem Cell transplant
like Bone Marrow transplant?
Answer: The preparation considerations are
similar. the Cord Blood Stem Cell donor is unrelated
and is an alternative for patient with out a brother
or sister match. The cost , time, and follow-up are
similar.
Question: I have a daughter that
have sickle cell. If she would have a step sibling.
Could she receive a bone narrow transplant if they
match? What risk would it be if they do match an her
body rejects the transplant?
Answer: The main concerns with sickle
cell bone marrow transplantation are (1) the immunologic
match between donor and recipient (HLA types) and
(2) the health status of your daughter.
1) A full HLA match between brothers or sisters will
have the very best chances for successful bone marrow
transplant (BMT). Lesser degrees of match means greater
chances of two bad outcomes:
1a) Graft Rejection (your child goes through the BMT
process but at the end her own bone marrow grows back
and she still has sickle cell disease) or 1b) Graft
Versus Host Disease (GVHD - the transplanted marrow
attacks the rest of your child's body as foreign tissue
and can cause great damage.
1c) very seldom will a person have a full HLA match
with half-siblings or parents, unless the family tree
is very inbred (for example, everyone is from the
same isolated village or clan and all are related
to each other's cousins. Therefore, your child's step-sister
would not have a high chance of being an HLA-matched
donor for BMT.
2) In addition to the chances of the two types of
problems listed above (Graft Rejection and GVHD),
there is a third set of bad problems that are side
effects of the harsh BMT treatment process. Death
may occur due to overwhelming infection,uncontrollable
bleeding, and failure of organs such as liver or kidney
or lungs. The chances that these bad side effects
will occur are probably greater if your child is in
worse health going into transplant. Therefore, the
general feeling among sickle cell doctors in North
and South America is that the only patients with severe
sickle cell complications should be offered BMT (because
only then are the high risks worthwhile), but that
they be in relatively good physical condition. Your
child may or may not meet these eligibility criteria.
HLA Matching for Bone Marrow Transplant
Question: What does HLA matched mean?
Answer:The short answer is: HLA match = immunologic
match.
The HLA markers on the surface of cells are what allows
the body to recognize that these cells are its own
("self") or somebody else ("non-self"). Usually physicians will
test for HLA in three classes: HLA-A, HLA-B, and HLA-DR,
but there are additional surface markers which are
not tested for. Each person has two possible inherited
types in each of these classes, which are designated
by numbers such as HLA-A4, A8 HLA-B27, B19 HLA- DR
1, 11. When all 6 of these are identical between a
pair of siblings, they probably inherited all the
same immunologic markers from their parents, and their
cells cannot be distiguished as different by the immune
system. This is the ideal set-up for a bone marrow
donor and host: HLA-matched siblings.
Any mismatch in the HLA types of two siblings means
that they inherited different types from their parents,
and that would not be a good set-up for bone marrow
transplant.
Finally, HLA-matching of unrelated people can be done,
drawing from computerized registries of tens of thousands
of people willing to be bone marrow donors (e.g. US
National Marrow Donor Program, others in other countries).
However, these unrelated people may match at all 6
of the markers for HLA-A, HLA-B,and HLA-DR but not
match at some of the other surface markers because
they are not from the same parents. The donor cells
would have a fairly high chance of being recognized
as foreign.
In each case of a mismatch, greater mismatch in HLA
type means higher chances of two bad outcomes: (1)
that donor cells would be attacked by the host immune
system (graft rejection), or (2) the immune system
that grows from the donor cells would attack the host
(graft vs. host disease). Also, children have
less risk of graft vs host disease than adults with
BMT.
For this reason, essentially all of the sickle cell
BMT have been from HLA-matched sibling donors, for
a child as the transplant recipient. The graft vs
host disease rate has been relatively low for sickle
cell children, but the graft rejection rate is higher
(10-12%) than that for BMT as cancer treatment. Why
the graft rejection rate is high for sickle cell BMT
is not understood. Matched unrelated donors from the
National Marrow Registry have not been used for sickle
cell BMT, although one matched unrelated cord blood
stem cell from the New York Cord Blood Registry has
been used (Atlanta, Dr. Andrew Yeager)
You might find additional information about bone marrow
transplant in broad terms from the National Marrow
Registry website. Info about HLA typing may be available
from organ donation and organ transplant centers,
since the same HLA matching is done for transplants
of heart, lungs, liver, kidney, etc. to prevent rejection
of the transplanted organ.
Question: How can I get a consultation about
bone marrow transplant
Answer: Write: aplatt@emory.edu or call the Comprehensive
Sickle Cell Center at 404-616-3572